Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001214659-25-014932
Filing Date
2025-10-14
Accepted
2025-10-14 15:41:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 8204
  Complete submission text file 0001214659-25-014932.txt   9878
Mailing Address 300 FIFTH AVENUE WALTHAM MA 02451
Business Address 300 FIFTH AVENUE WALTHAM MA 02451 617-430-5595
CRESCENT BIOPHARMA, INC. (Subject) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-87811 | Film No.: 251391585
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 333 PROVIDENCE HIGHWAY BOSTON MA 02062
Business Address 333 PROVIDENCE HIGHWAY BOSTON MA 02062 5148398866
1Globe Capital LLC (Filed by) CIK: 0001562189 (see all company filings)

EIN.: 800841812 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A